Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Baclofen in the Treatment of Alcohol Addiction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age ranging from 18 to 75 years~* diagnosis of alcohol dependence according to DSM IV criteria~* diagnosis of liver cirrhosis~* alcohol intake of at least 2 heavy drinking days (men \> 5 drinks/days; women \> 4 drinks/day) per week, on average and an average overall consumption of 21 drinks/week or more for men and 14 drinks/week or more for women during the 4 weeks prior to enrolment~* presence of a referred family member~Exclusion Criteria:~* severe heart or lung disease~* kidney alterations and/or hepato-renal syndrome~* tumours, including hepatocellular carcinoma~* metabolic diseases, including diabetes~* clinical signs of hepatic encephalopathy~* patients treated with interferon or corticosteroids within the last 60 days~* psychopathological illness undergoing treatment with psychoactive drugs~* epilepsy or epileptiform convulsions~* addiction to drugs other than nicotine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 2 (Type: PLACEBO_COMPARATOR): A total of 42 alcoholic patients with liver cirrhosis treated with placebo
- 1 (Type: ACTIVE_COMPARATOR): a total of 42 alcoholic patients with liver cirrhosis treated by baclofen

Based on this trial design, predict the completion outcome and termination type (if applicable).